Developing nations with greater market competition for antiretrovirals and more generic drugs tend to have cheaper antiretrovirals available through the private sector, according to a new study.
Developing nations with greater market competition for antiretrovirals and more generic drugs tend to have cheaper antiretrovirals available through the private sector, according to a new study.
Access to affordable drugs hinges on competition
November 1, 2004